What is the current Price Target for the Medicenna Therapeutics Corp stock?

The average Medicenna Therapeutics Corp target price is $2.35. This is 724.73% higher than the current stock price. The highest price target is 1,341.24%, the lowest is 302.04%. 6 Analysts have issued a price target Medicenna Therapeutics Corp 2027 .

How high will the Medicenna Therapeutics Corp stock rise?

No reliable answer can be given as to how high the Medicenna Therapeutics Corp stock will rise. The performance of stocks, including the Medicenna Therapeutics Corp stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Medicenna Therapeutics Corp stock today?

The performance of Medicenna Therapeutics Corp stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Medicenna Therapeutics Corp stock fall?

The decline in Medicenna Therapeutics Corp stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Medicenna Therapeutics Corp Forecast, price target & analysts

$0.29

0.00%

Nasdaq, Thu, Sep 24 2026.

ISIN

CA58490H1073

Symbol

MDNA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts News Strategies

Medicenna Therapeutics Corp Target price 2026 - Analyst rating & recommendation

Medicenna Therapeutics Corp Classifications & Recommendation

Buy

90%

Hold

10%

Medicenna Therapeutics Corp Price Target

Target Price	$2.35
Price	$0.29
Potential	724.73% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Medicenna Therapeutics Corp 2027 . The average Medicenna Therapeutics Corp target price is $2.35. This is 724.73% register free of charge higher than the current stock price. The highest price target is $4.11 1,341.24% register free of charge , the lowest is $1.15 302.04% register free of charge .
	A rating was issued by 10 analysts: 9 Analysts recommend Medicenna Therapeutics Corp to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Medicenna Therapeutics Corp stock has an average upside potential 2027 of 724.73% register free of charge . Most analysts recommend the Medicenna Therapeutics Corp stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Mar '26	2027 Estimates
Earnings Per Share $	-0.16	-0.25
	45.45%	56.25%
P/E		negative

5 Analysts have issued a Medicenna Therapeutics Corp forecast for earnings per share. The average Medicenna Therapeutics Corp EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2026. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2026	$-0.16	45.45%
2027	$-0.25 56.25% unlock
2028	$-0.14 44.00% unlock
2029	$-0.13 7.14% unlock

Current	-1.78	70.65%
2027	-1.13 36.56% unlock
2028	-2.07 83.19% unlock
2029	-2.25 8.70% unlock

Medicenna Therapeutics Corp...

Current Medicenna Therapeutics Corp Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
H.C. WAINWRIGHT & CO., LLC	Locked ➜ Locked	Locked	Aug 20 2026
RESEARCH CAPITAL CORPORATION	Locked ➜ Locked	Locked	Aug 14 2026
H.C. WAINWRIGHT & CO., LLC	Locked ➜ Locked	Locked	Jul 02 2026
H.C. WAINWRIGHT & CO., LLC	Locked ➜ Locked	Locked	Jul 01 2026
RESEARCH CAPITAL CORPORATION	Locked ➜ Locked	Locked	Jun 29 2026
RESEARCH CAPITAL CORPORATION	Locked ➜ Locked	Locked	Jun 28 2026
LUCID CAPITAL MARKETS, LLC	Locked ➜ Locked	Locked	Jun 26 2026

Analyst Rating	Date
Locked H.C. WAINWRIGHT & CO., LLC: Locked ➜ Locked	Aug 20 2026
Locked RESEARCH CAPITAL CORPORATION: Locked ➜ Locked	Aug 14 2026
Locked H.C. WAINWRIGHT & CO., LLC: Locked ➜ Locked	Jul 02 2026
Locked H.C. WAINWRIGHT & CO., LLC: Locked ➜ Locked	Jul 01 2026
Locked RESEARCH CAPITAL CORPORATION: Locked ➜ Locked	Jun 29 2026
Locked RESEARCH CAPITAL CORPORATION: Locked ➜ Locked	Jun 28 2026
Locked LUCID CAPITAL MARKETS, LLC: Locked ➜ Locked	Jun 26 2026

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 67.67%

Tencent Holdings Ltd. 55.89%

Uber Technologies 48.83%

Siemens Energy 47.15%

Adidas 46.64%

BYD 44.49%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now